Investor alert: law offices of howard g. smith announces investigation of ampio pharmaceuticals, inc. (ampe) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of ampio pharmaceuticals, inc. (“ampio” or the “company”) (nyse american: ampe) investors concerning the company's possible violations of federal securities laws. on april 20, 2022, ampio announced that the u.s. food and drug administration (“fda”) responded negatively to its type c meeting request for the company's ap-013 clinical trial and that the fda found the company should have sought the f
AMPE Ratings Summary
AMPE Quant Ranking